|1.||Voskuhl, Rhonda R: 8 articles (01/2016 - 10/2002)|
|2.||Currier, Robert J: 6 articles (10/2014 - 06/2009)|
|3.||Lagiou, Pagona: 6 articles (05/2014 - 04/2003)|
|4.||Hsieh, Chung-Cheng: 6 articles (05/2014 - 04/2003)|
|5.||Trichopoulos, Dimitrios: 6 articles (05/2014 - 04/2003)|
|6.||Jelliffe-Pawlowski, Laura L: 5 articles (10/2014 - 06/2009)|
|7.||Adami, Hans-Olov: 5 articles (05/2014 - 04/2003)|
|8.||Sicotte, Nancy L: 4 articles (01/2016 - 10/2002)|
|9.||Baer, Rebecca J: 4 articles (10/2014 - 08/2010)|
|10.||Nyberg, David A: 4 articles (09/2007 - 03/2002)|
12/01/1991 - "The paper reports the results of a study to assess the efficacy of an estriol-based cream (Colpogyn) in the topical treatment of postmenopausal vaginal atrophy. "
01/01/2011 - "Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy."
01/01/2011 - "This study evaluates the effect of intravaginal estriol on urogenital atrophy, Pap smear parameters, colposcopy parameters and discomfort during gynecological examination. "
06/01/2013 - "Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy."
10/01/2012 - "Estriol gel proved also superior in the improvement of several of the most outstanding vaginal signs of vaginal atrophy evaluated. "
09/28/2001 - "Estriol, which has little effect on the endometrium, has the potential to be highly useful for the treatment of atrophic vaginitis."
02/14/2005 - "In a randomized, double blind, controlled with placebo study, 27 women with climacteric symptoms and atrophic vaginitis were treated for 4 months with HT plus vaginal estriol 0.5 mg/day (group E) or placebo (group P). "
01/01/2013 - "Using Estriol in group 1 led to an increase in VHI, the appearance of lactobacilli in the vaginal smear, and the decrease of symptom frequency in atrophic vaginitis. "
01/01/2012 - "Estriol treatment resulted in a rise of vaginal health index (VHI), appearance of lactobacteria in the vaginal smear, lowering of atrophic vaginitis detection rate. "
01/01/2010 - "Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor®) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study."
|3.||Urinary Tract Infections (Urinary Tract Infection)
09/09/1993 - "We enrolled 93 postmenopausal women with a history of recurrent urinary tract infections in a randomized, double-blind, placebo-controlled trial of a topically applied intravaginal estriol cream. "
09/09/1993 - "A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections."
09/09/1993 - "Survival analysis showed that more of the women in the estriol group than in the placebo group remained free of urinary tract infection (P < 0.001). "
09/09/1993 - "The incidence of urinary tract infection in the group given estriol was significantly reduced as compared with that in the group given placebo (0.5 vs. 5.9 episodes per patient-year, P < 0.001). "
01/01/1987 - "Estriol in recurrent urinary tract infection in elderly women?"
01/01/2016 - "We assessed whether estriol treatment reduces multiple sclerosis relapses in women. "
10/01/2002 - "This novel treatment strategy of using pregnancy doses of estriol in multiple sclerosis has relevance to other autoimmune diseases that also improve during pregnancy."
04/01/2004 - "Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis."
04/12/1999 - "Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis."
01/01/2016 - "In a small single-arm study of people with multiple sclerosis estriol reduced gadolinium-enhancing lesions and was favourably immunomodulatory. "
|5.||Down Syndrome (Down's Syndrome)
02/01/1998 - "This compares favorably to the standard combination of MSAFP, hCG, and unconjugated estriol (E3), which had a 66.7% Down syndrome detection rate and a 4.1% screen positive rate in our study samples. "
03/01/1990 - "Study of 41 known Down syndrome cases and 441 matched controls did not confirm earlier reports that low unconjugated estriol levels can be used to detect fetal Down syndrome. "
01/01/2014 - "Unconjugated estriol (uE3) is routinely analyzed in clinical laboratories as risk assessment for Down syndrome. "
03/01/2012 - "Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome."
11/01/2007 - "Pregnant women are offered a biochemical screening test for Down syndrome in the second trimester, where the suspicion for SLOS could be registered, when the unconjugated estriol (uE3) level appears low. "
|1.||Vaginal Creams, Foams, and Jellies (Vaginal Tablet)
|4.||Chorionic Gonadotropin (Human Chorionic Gonadotropin)
|10.||Ethinyl Estradiol (Estinyl)
|4.||Hormone Replacement Therapy (Therapy, Hormone Replacement)